U.S. energy giants could soon move into Venezuela under President Trump’s directive, but experts warn the cost of doubling the country’s oil output may surpass $100 billion. A full recovery might not materialize until 2030, reflecting years of required rebuilding efforts.

AstraZeneca has unveiled a $2 billion plan to expand its manufacturing presence in Maryland, a move that marks its fourth U.S. commitment this year. The announcement highlights not only the company’s continued growth but also the broader impact such investments can have on America’s biotech landscape.